E-ISSN:2349-3267
P-ISSN:2349-5499

Research Article

Serratia marcescens

Pediatric Review - International Journal of Pediatric Research

2022 Volume 9 Number 2 March-April
Publisherwww.medresearch.in

Successful Source Identification and Control of an Outbreak of Serratia mercescens Bacteremia in NICU of a Tertiary Care Hospital in Eastern India

Ghosh A.1, Ghosh Uttam K.2, Hassan R.3, Pratim Halder P.4*, Poddar S.5
DOI: https://doi.org/10.17511/ijpr.2022.i02.02

1 Aniruddha Ghosh, Assistant Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

2 Kheya Ghosh Uttam, Assistant Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

3 Rafiqul Hassan, Assistant Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

4* Partha Pratim Halder, Assistant Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

5 Sumon Poddar, Associate Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.

Introduction: S. marcescens can cause potentially fatal sepsis, especially in premature and low birth weight babies. The result of an outbreak in any hospital is grave and requires thorough environmental sampling for source identification. Purpose: The objective of our study was to identify the source of the Serratia marcescens outbreak among the neonates admitted to the Neonatal Intensive Care Unit (NICU) of a tertiary care pediatric hospital. Seven neonates were affected in this outbreak and the index case, unfortunately, died. Materials &Methods: Apart from attempts to isolate organisms from neonates with sepsis, extensive environmental sampling in the form of swabs were collected from all surfaces like walls, floors, cradles, ventilators etc. and instruments like milk collecting devices, intravenous fluid and drug bottles etc. as well as from hands, stethoscopes, mobile phones of doctors and nursing staffs. Swabs were cultured to isolate S. marcescens, and a sensitivity pattern was noted. Results: Among the 78 samples studied, S. marcescens was isolated from a running intravenous fluid bottle and a normal saline bottle used for reconstituting intravenous fluids for the neonates. These isolates showed the same sensitivity patterns as those obtained from the affected neonates. Elimination of sources, appropriate antibiotic therapy and constant surveillance, achieved successful outbreak control. Conclusions: Extensive environmental sampling to find out the point source, and after that, active surveillance is necessary to control such infections. Besides source control and appropriate antibiotic therapy, implementing and reinforcing routine measures such as hand hygiene are compulsory in these outbreaks.

Keywords: Serratia marcescens, Neonatal intensive care unit, Outbreak, Hand hygiene, Newborn, Sepsis

Corresponding Author How to Cite this Article To Browse
Partha Pratim Halder, Assistant Professor, Department of Pediatric Medicine, Institute of Child Health, Kolkata, West Bengal, India.
Email:
Aniruddha Ghosh, Kheya Ghosh Uttam, Rafiqul Hassan, Partha Pratim Halder, Sumon Poddar, Successful Source Identification and Control of an Outbreak of Serratia mercescens Bacteremia in NICU of a Tertiary Care Hospital in Eastern India. Pediatric Rev Int J Pediatr Res. 2022;9(2):6-13.
Available From
https://pediatrics.medresearch.in/index.php/ijpr/article/view/717

Manuscript Received Review Round 1 Review Round 2 Review Round 3 Accepted
2022-04-07 2022-04-09 2022-04-16 2022-04-23 2022-04-30
Conflict of Interest Funding Ethical Approval Plagiarism X-checker Note
Nil Nil Yes 17%

© 2022by Aniruddha Ghosh, Kheya Ghosh Uttam, Rafiqul Hassan, Partha Pratim Halder, Sumon Poddarand Published by Siddharth Health Research and Social Welfare Society. This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License https://creativecommons.org/licenses/by/4.0/ unported [CC BY 4.0].

Introduction

Serratia is a genus of Gram-negative, non-spore-forming, rod-shaped bacteria belonging to the tribe Klebsielleae of the family Enterobacteriaceae. It is oxidase negative and typically a glucose-fermenter; Serratia species are Voges Proskauer positive and reduce nitrate to nitrite [1,2]. To date, 14 species of the genus Serratia have been identified, among which S. marcescens is the most common one isolated from clinical specimens [3,4]. First described in 1819 by an Italian pharmacist Bartolomeo Bizio[5], S.marcescens was at first presumed to be a non-pathogenic saprophyte. Because of detectable red pigment in many strains, it has been widely used as a tracer organism for pathogens used in bioterrorism during World War I and even until 1968 [5]. It is now a well-known human pathogen, the first probable adult case report dating back to 1913 [6]. The first report of an outbreak in a pediatric ward, along with the first neonatal mortality due to hospital-acquired S.marcescens infection, was reported in Israel in 1951-52 by Rabinowitz and Schiffrin[7].S. marcescens has been implicated in about 15% of opportunistic nosocomial infections in neonatal intensive care units[8]. In neonates, it can cause conjunctivitis, sepsis/bacteremia, pneumonia, meningitis, brain abscess etc.[5, 9]. Urinary tract infections, wound infections etc., have also been noted in pediatric patients [5]. Most of the published data show that infected infants are the main reservoirs as they harbour the organisms, often asymptomatically, in their gastrointestinal tracts despite prolonged antibiotic treatment and cause cross-transmission by the hands of health care workers working in NICUs [5, 10]. Apart from the patients, almost all the equipment, washbasins, and intravenous preparations used in NICUs have been incriminated as a source of infections. These ubiquitous organisms thrive well in soil and moist surfaces [5]. Biofilm formation by S. mercescens, observed by several researchers, may be another important factor in this regard [11,12]. Epidemic outbreaks in NICUs by this organism spread rapidly and are associated with significant neonatal mortality [13,14,15]. It has been observed that there has been an increasing trend of S.marcescens outbreaks in NICUs throughout the last decades [16]. Management of S. marcescens infections is a nightmare for clinicians. Apart from its intrinsic resistance to several antibiotics,

it also acquires resistance to antibiotics, including beta-lactams, Aminoglycosides, quinolones etc., and transfers it from one strain to another very rapidly by chromosomal as well as plasmid-mediated determinants [5]. Thus hospital-acquired S. marcescens infections often prove devastating in neonates admitted with severe illnesses to neonatal intensive care units.

In our NICU, we have encountered a similar outbreak of Serratia marcescens and launched a thorough investigation to identify the source. Here we shall discuss the details of this outbreak investigation and the successful management of the situation with our limited resources.

Materials And Methods

This study was done over one month (December 2019). The study was conducted in a 150-bed tertiary care teaching hospital in Kolkata, India. The study subjects were newborns admitted to the NICU in December 2019. The NICU has 20 beds admitting critically ill neonates. The unit admits between 300-400 patients annually. In December 2019, an outbreak of systemic infections caused by Serratia marcescens occurred in the NICU. A total of seven patients were affected by this outbreak. Clinical details of cases were recorded by using a predesigned proforma. Sepsis was determined if blood culture showed positive results with clinical features [lethargy, feed intolerance, clinical features of shock with metabolic acidosis, tachypnoea/apnoea, tachycardia, fever/hypothermia] suggestive of sepsis and presence of routine haematological/biochemical parameters consistent with sepsis [rise/fall of total leukocyte count or increase in immature forms or rising C-reactive protein, micro-ESR etc.]Extensive environmental microbiological investigation was done. Conjunctival and rectal swabs from all the patients were sent. Swabs were taken from numerous surfaces, including walls, floors, door handles, shelves, sinks, hoods, cradles, ventilators, stethoscopes, other medical devices, milk collecting devices, trolleys, and medical record books. To find out about human transmission, hand swabs and swabs from mobile phones were taken from doctors and nurses working in NICU. Intravenous fluid samples from running bottles, bottles for fluid preparation, drug bottles, soaps and disinfectants were either swabbed or cultured. Also, sample


swabs were collected from the obstetrics ward, labour room and operation theatre, where caesarean sections were performed. A total of 78 samples were taken and cultured.

Cultures were done by automated blood culture system BACTEC 9050, and isolates, if any, were identified by standard microbiological techniques. Antibiotic susceptibility was done by Kirby Bauer disk diffusion method following CLSI guidelines. Apart from the investigation of the cause thorough sanitation procedure commenced. Possible sources were disposed of and renewed, including linens, cotton, parenteral nutrition, milk collecting devices, disinfectants, soaps etc. Hand washing, the use of alcohol-based hand sanitisers use of gloves when assisting in procedures or handling infants were reinforced.

Results

Seven neonates developed clinical sepsis with positive blood cultures, and unfortunately, the index case died.

Four out of 7 affected neonates were girls (57.14%). The mean gestational age of the babies was 36.4 weeks, the range being 32-40 weeks. Mean birth weight was 1.820 kg, the range being 1.300 kg-2.220 kg. Four patients (cases 2,3,5, and 6) had indwelling devices (requiring mechanical ventilation, central venous lines, total parenteral nutrition etc.). The clinical characteristics associated with underlying disorders in these cases are shown in Table 1.

Table 1: Clinical characteristics of the affected neonates at the time of admission.

Case No Age(days) Gestational age (weeks) Underlying problem
1 4 38 Neonatal seizure
2 4 37 Hypoxic-ischemic encephalopathy
3 1 33 Preterm, very low birth weight
4 11 37 Hypoxic-ischemic encephalopathy
5 8 40 Meconium aspiration syndrome
6 5 32 Preterm, very low birth weight
7 1 38 Transient tachypnea of the newborn

The index case (case 1) was a neonate transferred from another hospital due to neonatal seizures

and did not have sepsis at the time of admission. This patient developed sepsis on day 3 of admission. Blood culture showed S. marcescens growth sensitive to all antibiotics except Colistin and Polymyxin B. Intravenous cefotaxime and gentamicin were started following the sensitivity pattern. Within three days of receipt of the culture positivity report of the index case, other 6 cases were identified despite reinforcing all the control measures.

One neonate (case 5) developed right-sided pneumonia, and S. mercescens was isolated from the bronchoalveolar lavage fluid too. It was possible to do lumbar punctures in all the cases, and the reports were within normal limits.

By this time, culture reports of patients’ conjunctival and rectal swabs were negative for S. mercescens. Swabs and samples from inanimate surfaces, equipment, antiseptics, humidifiers, and hands of all doctors and nurses were negative. But S. marcescens was isolated from a running IV fluid bottle of an unaffected term neonate. The same organism was also found in a normal saline bottle used for reconstituting IV fluids for the neonates.

These isolates showed the same sensitivity patterns as those obtained from the affected neonates.

The sources incriminated by our investigation were already replaced while applying the control measures.

Unfortunately, the index case died after seven days of antibiotic therapy due to septic shock. Like the index case, all other cases were started on intravenous cefotaxime and gentamicin combination as per the blood culture sensitivity report. Blood counts and C-reactive protein (CRP) were repeated frequently. Like the index case, the other cases showed no improvement, neither clinically nor in the laboratory parameters (CRP, immature/mature white blood cell ratio, white cell count etc.).So suspecting derepression of AmpC β- lactamase while on third-generation cephalosporin, the ongoing treatment plan was reviewed, and antibiotics were switched to intravenous meropenem (40 mg/kg per day in three divided doses). After fourteen days of antibiotic therapy, a complete cure was achieved.

No S.marcescens was isolated in the 12-months follow up period of this outbreak.


Discussion

Since the 1980s, large numbers of S.marcescens outbreaks have been described in neonatal and pediatric ICUs, neonatal nurseries, special care baby units, pediatric oncology wards and maternity wards [5]. There have been many reports of such outbreaks from different parts of the world in recent years affecting patients admitted to NICUs [13, 17, 18, and 19], where newborns who have an immature immune system compared to adults are treated for various health issues [19].S. marcescens can cause potentially fatal sepsis, meningitis or pneumonia especially in premature and low birth weight babies [10, 20]. Reported mortality rates associated with recent S. marcescens outbreaks in NICUs vary, ranging from 10% and 20% [19, 21, and 22]. In our study, mortality was 14.28% which is comparable to other study findings.

Moles et al., in their article analyzing neonatal faecal microbiota, showed that the presence of Serratia was strongly associated with a higher degree of immaturity and other hospital-related parameters like mechanical ventilation etc. [23]. There are several other studies, i.e. study by Voeltz et al. that concluded that risk factors for these outbreaks include the length of NICU stay, exposure to the hands of health care providers and use of prolonged antibiotic therapy that may destroy the normal gut flora of the neonates [10, 24, and 25]. In our study, among the seven study subjects, four (case 2, 3, 5, 6) (57.14%) required one or more of the followings: prolonged NICU stay, frequent handling by health care providers, mechanical ventilation, central venous line and prolonged parenteral nutrition and antibiotic therapy.

Failure to control sepsis in the index case (receiving intravenous cefotaxime- a third-generation cephalosporin and gentamicin- an aminoglycoside) was treated following an antibiotic-susceptibility pattern explained by the rapid evolution of antibiotic resistance observed in S. marcescens. The chromosomal ampC genes of S. marcescens are inducible by various beta-lactam antibiotics by a complex mechanism involving cell wall recycling [26]. The 2011 Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing (M100-S21) [27] stated this warning: “Serratia may develop resistance during prolonged therapy

with third-generation cephalosporins. Therefore, isolates that are initially susceptible may become resistant within 3 to 4 days after initiation of therapy.” One such outbreak was reported in Italy from 2001 to 2002, probably due to ampC derepression or induction, where before isolation of S. marcescens, neonates were being routinely treated with various beta-lactam antibiotics just like our NICU.

S. marcescens can acquire resistance to Aminoglycosides most commonly via genes located on plasmids containing aminoglycoside-modifying enzymes, which by modifying the antibiotic binding sites on ribosomes, render Aminoglycosides ineffective [5]. This organism is also notorious for expressing Extended Spectrum Beta Lactamases (ESBL) by many strains [5]. In India, Rizvi and others observed 33% ESBL producing Serratia species from 2007 to 2008 by analysis of clinical samples [28]. Since the publication of the first outbreak with carbapenemase-producing S. mercescens in Argentina [29], Very few such cases have been reported, and carbapenems are regarded as a good treatment option in suspected S. marcescens infections. We, too, found success treating six of the study subjects after switching over to intravenous meropenem when the index case died.

S. marcescens can spread rapidly and cause substantial mortality and morbidity [30]. Voeltz et al. [10] stated in their article that two or more nosocomially related inpatient S. marcescens cases indicate a potential outbreak that should be investigated thoroughly to prevent further progress. Although in a large number of published neonatal S.marcescens outbreaks source could not be identified. Investigators have reported that during S. marcescens outbreaks, standard hygienic measures may prove insufficient to halt the aggressive spread of this organism. In such conditions, cohort nursing and even temporary closure of the unit should be considered [30].

Affected neonates have often been incriminated as the most important reservoirs in S. marcescens outbreaks by most of the published studies [10]. S. marcescens is not a natural intestinal flora of neonates [31]; rather, they acquire this bacterium through contaminated feeds [32]. Also, neonates in NICUs often suffer from bacterial conjunctivitis, and S. marcescens is a proven major pathogen


in these cases. However, our investigation could not find any Serratia isolates in the rectal or conjunctival swabs of the study subjects.

Hand colonization and hand carriage are incriminated as important sources of infection as the organism can live on human skin for a long period [33]. High patient density and low nurse-to-patient ratio, as observed often in developing countries, have been reported to cause the spread of pathogens by contaminated hands of health care workers [34]. S. marcescens has got colonization rates on the hands of healthcare workers ranging from 15.4% to 24% [35]. In our study, though, all the hand swabs yielded negative results.

Fortunately, in our study, we could identify the source. S. marcescens was isolated from swabs from one running fluid bottle and another fluid bottle used for mixing and preparing intravenous fluid solutions. The investigation of the first pediatric outbreak of S. marcescens by Rabinowitz and schiffrin in 1952 revealed a similar point source, contaminated intravenous solution as the culprit [7]. Also, in 1966, McCormack and Kunin investigated a similar outbreak in a baby nursery and incriminated contaminated saline in their report [36].

Apart from these point sources, other possible sources of S. marcescens outbreaks in NICU could be enlisted as follows: contaminated breast milk, formula, breast pump, parenteral nutrition, incubators, laryngoscopes, soap and soap dispensers, suction tubes, air conditioning ducts, waste jars, contaminated hand brush, multidose medications and nebulizer dropper bottles etc. In our study, swabs or samples from all these sources were cultured, but no isolate was found. We could not use typing methods such as sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), plasmid profiling etc. which are very useful in outbreak scenarios but are not readily available in all the parts of third world countries like India.

Conclusion

Serratia marcescens outbreaks in NICU pose a grave threat to clinicians and epidemiologists. Frequently the source of such an outbreak cannot be pinpointed. However, Extensive environmental sampling to find out the point source and after that, active surveillance is necessary to control

such infections. Molecular technologies, though not readily accessible in third world countries, can help to an immense extent. Conjunctival and rectal swabs from all neonates are necessary to culture. Also, the culture of swabs collected from the hands of healthcare workers is of paramount importance. Implementation and reinforcement of routine measures such as hand hygiene are compulsory in these outbreaks. Carbapenems, especially meropenem, are good empiric therapy in suspected S. marcescens infections.

Authors’ Contributions: Authors Poddar S and Halder PP collected the data. Hassan R did the compilation of data. Poddar S, Halder PP and Hassan R wrote the primary manuscript. Ghosh A and Uttam KG wrote the final manuscript.

What does the present study add to existing knowledge? Extensive environmental sampling to find out the point source and, after that, active surveillance is necessary to control outbreaks in NICUs, especially in developing countries where molecular technologies are not readily available.

Reference

01. Farmer III, J. J. , K. D. Boatwright, and J. M. Janda. Enterobacteriaceae: introduction and identification, p 649–669. Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC (2007) [Crossref][PubMed][Google Scholar]

02. Grimont, F. , and P. A. D. Grimont. Genus XXXIV. Serratia Bizio 1823, 288AL. Bergey’s Manual of Systematic Bacteriology, edited by DJ Brenner, NR Krieg and JT Staley. New York: Springer (2005) [Crossref][PubMed][Google Scholar]

03. . . A. D. Grimont. Genus XXXIV. Serratia Bizio 1823, 288AL. Bergey’s Manual of Systematic Bacteriology, edited by DJ Brenner, NR Krieg and JT Staley. New York: Springer (2005) [Crossref][PubMed][Google Scholar] [Crossref][PubMed][Google Scholar]

04. Gossard, Kimberly A. Genetic profiling of the white pox disease coral pathogen Serratia marcescens from the Florida Keys. (2014). [Crossref][PubMed][Google Scholar]

05. Laupland KB, Parkins MD, Gregson DB, Church DL, Ross T, Pitout JD. Population-based laboratory surveillance for Serratia species isolates in a


large Canadian health region. Eur J Clin Microbiol Infect Dis. 2008 Feb;27(2):89-95. doi: 10.1007/s10096-007-0400-7 [Crossref][PubMed][Google Scholar]

06. Mahlen SD. Serratia Infections: from military experiments to current practice. Clin Microbiol Rev 2011 Oct; 24(4):755-91. [Crossref][PubMed][Google Scholar]

07. Woodward, H. M. M. , and K. B. Clarke. A case of infection in man by the Bacterium prodigiosum." The Lancet 181.4666 (1913): 314-315 [Crossref][PubMed][Google Scholar]

08. Rabinowitz K, Schiffrin R. A ward-contamination by Serratia marcescens. Acta Med Orient. 1952 Oct;11(10):181-4. [Crossref][PubMed][Google Scholar]

09. Raymond J, Aujard Y. Nosocomial infections in pediatric patients: a European, multicenter prospective study. European Study Group. Infect Control Hosp Epidemiol. 2000 Apr;21(4):260-3. doi: 10.1086/501755 [Crossref][PubMed][Google Scholar]

10. Polilli E, Parruti G, Fazii P, D'Antonio D, Palmieri D, D'Incecco C, et al. Rapidly controlled outbreak of Serratia marcescens infection/colonisations in a neonatal intensive care unit, Pescara General Hospital, Pescara, Italy, April 2011. Euro Surveill. 2011 Jun 16;16(24):19892. doi: 10.2807/ese.16.24.19892-en [Crossref][PubMed][Google Scholar]

11. Voelz A, Müller A, Gillen J, Le C, Dresbach T, Engelhart S, et al. Outbreaks of Serratia marcescens in neonatal and pediatric intensive care units: clinical aspects, risk factors and management. Int J Hyg Environ Health. 2010 Mar;213(2):79-87. doi: 10.1016/j.ijheh.2009.09.003 [Crossref][PubMed][Google Scholar]

12. Liu X, Jia J, Popat R, Ortori CA, Li J, Diggle SP, et al. Characterization of two quorum sensing systems in the endophytic Serratia plymuthica strain G3: differential control of motility and biofilm formation according to life-style. BMC Microbiol. 2011 Feb 1;11(1):26. doi: 10.1186/1471-2180-11-26 [Crossref][PubMed][Google Scholar]

13. Shanks RM, Stella NA, Kalivoda EJ, Doe MR, O'Dee DM, Lathrop KL, et al. A Serratia marcescens

OxyR homolog mediates surface attachment and biofilm formation. J Bacteriol. 2007 Oct;189(20):7262-72. doi: 10.1128/JB.00859-07 [Crossref][PubMed][Google Scholar]

14. Jang TN, Fung CP, Yang TL, Shen SH, Huang CS, Lee SH. Use of pulsed-field gel electrophoresis to investigate an outbreak of Serratia marcescens infection in a neonatal intensive care unit. J Hosp Infect. 2001 May;48(1):13-9. doi: 10.1053/jhin.2001.0947 [Crossref][PubMed][Google Scholar]

15. Miranda G, Kelly C, Solorzano F, Leanos B, Coria R, Patterson JE. Use of pulsed-field gel electrophoresis typing to study an outbreak of infection due to Serratia marcescens in a neonatal intensive care unit. J Clin Microbiol. 1996 Dec;34(12):3138-41. doi: 10.1128/jcm.34.12.3138-3141.1996 [Crossref][PubMed][Google Scholar]

16. Smith PJ, Brookfield DS, Shaw DA, Gray J. An outbreak of Serratia marcescens infections in a neonatal unit. Lancet. 1984 Jan 21;1(8369):151-3. doi: 10.1016/s0140-6736(84)90074-6 [Crossref][PubMed][Google Scholar]

17. Miranda-Novales G, Leaños-Miranda B, Díaz-Ramos R, González-Tejeda L, Peregrino-Bejarano L, Villegas-Silva R, et al. An outbreak due to Serratia marcescens in a neonatal intensive care unit typed by 2-day pulsed field gel electrophoresis protocol. Arch Med Res. 2003 May-Jun;34(3):237-41. doi: 10.1016/S0188-4409(03)00026-2 [Crossref][PubMed][Google Scholar]

18. Lai KK, Baker SP, Fontecchio SA. Rapid eradication of a cluster of Serratia marcescens in a neonatal intensive care unit: use of epidemiologic chromosome profiling by pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol. 2004 Sep;25(9):730-4. doi: 10.1086/502468 [Crossref][PubMed][Google Scholar]

19. Steppberger K, Walter S, Claros MC, Spencker FB, Kiess W, Rodloff AC, et al. Nosocomial neonatal outbreak of Serratia marcescens--analysis of pathogens by pulsed field gel electrophoresis and polymerase chain reaction. Infection. 2002 Oct;30(5):277-81. doi: 10.1007/s15010-002-2141-y [Crossref][PubMed][Google Scholar]

20. Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. Case-control analysis


of endemic Serratia marcescens bacteremia in a neonatal intensive care unit. Arch Dis Child Fetal Neonatal Ed. 2007 Mar;92(2):F120-6. doi: 10.1136/adc.2006.102855 [Crossref][PubMed][Google Scholar]

21. Anderson B, Nicholas S, Sprague B, Campos J, Short B, Singh N. Molecular and descriptive epidemiologyof multidrug-resistant Enterobacteriaceae in hospitalized infants. Infect Control Hosp Epidemiol. 2008 Mar;29(3):250-5. doi: 10.1086/527513 [Crossref][PubMed][Google Scholar]

22. Fleisch F, Zimmermann-Baer U, Zbinden R, Bischoff G, Arlettaz R, Waldvogel K, et al. Three consecutive outbreaks of Serratia marcescens in a neonatal intensive care unit. Clin Infect Dis. 2002 Mar 15;34(6):767-73. doi: 10.1086/339046 [Crossref][PubMed][Google Scholar]

23. Arslan U, Erayman I, Kirdar S, Yuksekkaya S, Cimen O, Tuncer I, et al. Serratia marcescens sepsis outbreak in a neonatal intensive care unit. Pediatr Int. 2010 Apr;52(2):208-12. doi: 10.1111/j.1442-200X.2009.02934.x [Crossref][PubMed][Google Scholar]

24. Moles L, Gómez M, Heilig H, Bustos G, Fuentes S, de Vos W, et al. Bacterial diversity in meconium of preterm neonates and evolution of their fecal microbiota during the first month of life. PLoS One. 2013 Jun 28;8(6):e66986. doi: 10.1371/journal.pone.0066986 [Crossref][PubMed][Google Scholar]

25. Crivaro V, Bagattini M, Salza MF, Raimondi F, Rossano F, Triassi M, et al. Risk factors for extended-spectrum beta-lactamase-producing Serratia marcescens and Klebsiella pneumoniae acquisition in a neonatal intensive care unit. J Hosp Infect. 2007 Oct;67(2):135-41. doi: 10.1016/j.jhin.2007.07.026 [Crossref][PubMed][Google Scholar]

26. Friedman ND, Kotsanas D, Brett J, Billah B, Korman TM. Investigation of an outbreak of Serratia marcescens in a neonatal unit via a case-control study and molecular typing. Am J Infect Control. 2008 Feb;36(1):22-8. doi: 10.1016/j.ajic.2006.12.012 [Crossref][PubMed][Google Scholar]

27. Hanson ND, Sanders CC. Regulation of inducible AmpC beta-lactamase expression

among Enterobacteriaceae. Curr Pharm Des. 1999 Nov;5(11):881-94. [Crossref][PubMed][Google Scholar]

28. Wayne, P. A. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 20th informational supplement. " CLSI document M100-S20 (2010). [Crossref][PubMed][Google Scholar]

29. Rizvi M, Fatima N, Rashid M, Shukla I, Malik A, Usman A, et al. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay. J Infect Dev Ctries. 2009 May 1;3(4):285-94 [Crossref][PubMed][Google Scholar]

30. Nastro M, Monge R, Zintgraff J, Vaulet LG, Boutureira M, Famiglietti A, et al. First nosocomial outbreak of VIM-16-producing Serratia marcescens in Argentina. Clin Microbiol Infect. 2013 Jul;19(7):617-9. doi: 10.1111/j.1469-0691.2012.03978.x [Crossref][PubMed][Google Scholar]

31. Zaidi M, Sifuentes J, Bobadilla M, Moncada D, Ponce de León S. Epidemic of Serratia marcescens bacteremia and meningitis in a neonatal unit in Mexico City. Infect Control Hosp Epidemiol. 1989 Jan;10(1):14-20. doi: 10.1086/645909 [Crossref][PubMed][Google Scholar]

32. Almuneef MA, Baltimore RS, Farrel PA, Reagan-Cirincione P, Dembry LM. Molecular typing demonstrating transmission of gram-negative rods in a neonatal intensive care unit in the absence of a recognized epidemic. Clin Infect Dis. 2001 Jan 15;32(2):220-7. doi: 10.1086/318477 [Crossref][PubMed][Google Scholar]

33. Oie S, Kamiya A, Hironaga K, Koshiro A. Microbial contamination of enteral feeding solution and its prevention. Am J Infect Control. 1993 Feb;21(1):34-8. doi: 10.1016/0196-6553(93)90205-i [Crossref][PubMed][Google Scholar]

34. Macdonald TM, Langley JM, Mailman T, Allain K, Nelson G, Hatton L, et al. Serratia marcescens outbreak in a neonatal intensive care unit related to the exit port of an oscillator. Pediatr Crit Care Med. 2011 Nov;12(6):e282-6. doi: 10.1097/PCC.0b013e31820ac42a [Crossref][PubMed][Google Scholar]


35. Gillespie EE, Bradford J, Brett J, Kotsanas D. Serratia marcescens bacteremia - an indicator for outbreak management and heightened surveillance. J Perinat Med. 2007;35(3):227-31. doi: 10.1515/JPM.2007.043 [Crossref][PubMed][Google Scholar]

36. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev. 2004 Oct;17(4):863-93, table of contents. doi: 10.1128/CMR.17.4.863-893.2004 [Crossref][PubMed][Google Scholar]

37. McCormack RC, Kunin CM. Control of a single source nursery epidemic due to Serratia marcescens. Pediatrics. 1966 May;37(5):750-5. [Crossref][PubMed][Google Scholar]